Literature DB >> 9310565

Publication bias: evidence of delayed publication in a cohort study of clinical research projects.

J M Stern1, R J Simes.   

Abstract

OBJECTIVES: To determine the extent to which publication is influenced by study outcome.
DESIGN: A cohort of studies submitted to a hospital ethics committee over 10 years were examined retrospectively by reviewing the protocols and by questionnaire. The primary method of analysis was Cox's proportional hazards model.
SETTING: University hospital, Sydney, Australia. STUDIES: 748 eligible studies submitted to Royal Prince Alfred Hospital Ethics Committee between 1979 and 1988. MAIN OUTCOME MEASURES: Time to publication.
RESULTS: Response to the questionnaire was received for 520 (70%) of the eligible studies. Of the 218 studies analysed with tests of significance, those with positive results (P < 0.05) were much more likely to be published than those with negative results (P > or = 0.10) (hazard ratio 2.32 (95% confidence interval 1.47 to 3.66), P = 0.0003), with a significantly shorter time to publication (median 4.8 v 8.0 years). This finding was even stronger for the group of 130 clinical trials (hazard ratio 3.13 (1.76 to 5.58). P = 0.0001), with median times to publication of 4.7 and 8.0 years respectively. These results were not materially changed after adjusting for other significant predictors of publication. Studies with indefinite conclusions (0.05 < or = P < 0.10) tended to have an even lower publication rate and longer time to publication than studies with negative results (hazard ratio 0.39 (0.13 to 1.12), P = 0.08). For the 103 studies in which outcome was rated qualitatively, there was no clear cut evidence of publication bias, although the number of studies in this group was not large.
CONCLUSIONS: This study confirms the evidence of publication bias found in other studies and identifies delay in publication as an additional important factor. The study results support the need for prospective registration of trials to avoid publication bias and also support restricting the selection of trials to those started before a common date in undertaking systematic reviews.

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  1997        PMID: 9310565      PMCID: PMC2127436          DOI: 10.1136/bmj.315.7109.640

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  181 in total

1.  Registering clinical trials.

Authors:  A Tonks
Journal:  BMJ       Date:  1999-12-11

Review 2.  Recommendations for future studies: a systematic review of educational interventions in primary care settings.

Authors:  U Freudenstein; A Howe
Journal:  Br J Gen Pract       Date:  1999-12       Impact factor: 5.386

3.  Having non-medical readers of papers on internet will enhance peer review.

Authors:  P Whatling
Journal:  BMJ       Date:  1999-04-24

4.  Relationships fade with time: a meta-analysis of temporal trends in publication in ecology and evolution.

Authors:  Michael D Jennions; Anders P Møller
Journal:  Proc Biol Sci       Date:  2002-01-07       Impact factor: 5.349

Review 5.  Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis.

Authors:  J A Sterne; M Egger; G D Smith
Journal:  BMJ       Date:  2001-07-14

6.  Quality of Cochrane reviews: assessment of sample from 1998.

Authors:  O Olsen; P Middleton; J Ezzo; P C Gøtzsche; V Hadhazy; A Herxheimer; J Kleijnen; H McIntosh
Journal:  BMJ       Date:  2001-10-13

7.  Why we need a broad perspective on meta-analysis. It may be crucially important for patients.

Authors:  P C Gotzsche
Journal:  BMJ       Date:  2000-09-09

8.  Getting it right: industry sponsorship and medical research.

Authors:  Patricia Baird
Journal:  CMAJ       Date:  2003-05-13       Impact factor: 8.262

Review 9.  Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

Authors:  Joel Lexchin; Lisa A Bero; Benjamin Djulbegovic; Otavio Clark
Journal:  BMJ       Date:  2003-05-31

Review 10.  Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications.

Authors:  Hans Melander; Jane Ahlqvist-Rastad; Gertie Meijer; Björn Beermann
Journal:  BMJ       Date:  2003-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.